NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Synchrony Financial (“Synchrony” or the “Company”) (NYSE: SYF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
Month: February 2025
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Construction Partners, Inc. (“Construction Partners” or the “Company”) (NYSE: ROAD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext….
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Owens & Minor, Inc (“Owens & Minor” or the “Company”) (NYSE:OMI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of XPLR Infrastructure, LP (f/k/a NextEra Energy Partners, LP) (“XPLR” or the “Company”) (NYSE: NER). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Electronic Arts Inc. (“Electronic Arts” or the “Company”) (NASDAQ: EA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of JinkoSolar Holding Co., Ltd. (“JinkoSolar” or the “Company”) (NYSE: JKS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Intellia Therapeutics, Inc (“Intellia” or the “Company”) (NASDAQ :NTLA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, Feb. 18, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sonos, Inc. (“Sonos” or the “Company”) (NASDAQ: SONO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
The PDA/ANSI Standard 03-2025, Standard Practice for Quality Risk Management of Aseptic Processes outlines a Quality Risk Management (QRM) method for assessing and controlling contamination risks in aseptic processing. BETHESDA, Md., Feb. 18, 2025 /PRNewswire-PRWeb/ — The PDA/ANSI…